Cancer

Items 11-20 of 71

per page
Set Descending Direction
  1. CD152 [CTLA-4] (human) (rec.) (untagged)
    AG-40B-0232
    AG-40B-0232-C05050 µg
    CHF 220.00
    CD152 [CTLA-4] (human) (rec.) (untagged)
  2. CD38 (human) (rec.) (His) (active) (10µg)
    BBL-2275
    BBL-2275-C01010 µg
    CHF 782.00
    CD38 (human) (rec.) (His) (active) (10µg)
  3. CD38 (human) (rec.) (His) (active) (1µg)
    BBL-2274
    BBL-2274-C0011 µg
    CHF 441.00
    CD38 (human) (rec.) (His) (active) (1µg)
  4. Clusterin (nuclear form) (human) (rec.) (His)
    AG-40A-0047
    AG-40A-0047-C05050 µg
    CHF 380.00
  5. Clusterin (nuclear form) (mouse) (rec.) (His)
    AG-40A-0057
    AG-40A-0057-C05050 µg
    CHF 380.00
  6. Clusterin (secretory form) (human) (rec.)
    AG-40A-0050Y
    AG-40A-0050Y-C01010 µg
    CHF 190.00
    AG-40A-0050Y-C05050 µg
    CHF 380.00
    After denaturation of recombinant secretory clusterin in the presense of β-mercaptoethanol followed by boiling, two distinct bands, 60kDa and 35kDa, were seperated on SDS-PAGE. The two bands were extracted and subjected to determination of their N-te
  7. COMP (rat):Angiopoietin-1 (human) (rec.)
    AG-40B-0147
    AG-40B-0147-C01010 µg
    CHF 250.00
    AG-40B-0147-C05050 µg
    CHF 840.00
    AG-40B-0147-50105 x 10 µg
    CHF 850.00
    BULK available!
    COMP (rat):Angiopoietin-1 (human) (rec.) (AG-40B-0147) binds to Tie-2 (human):Fc (human). Method: Tie-2 (human):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations of COMP (rat):Angiopoietin-1 (huma
  8. CREB-binding Protein (mouse) (rec.) (His) (highly active)
    AG-40T-0016
    AG-40T-0016-C0022 µg
    CHF 290.00
  9. CTHRC1 (human) (rec.)
    AG-40B-0157
    AG-40B-0157-C01010 µg
    CHF 335.00
    AG-40B-0157-30103 x 10 µg
    CHF 670.00
  10. CTHRC1 (mouse) (rec.)
    AG-40B-0154
    AG-40B-0154-C01010 µg
    CHF 350.00
    AG-40B-0154-30103 x 10 µg
    CHF 695.00

Items 11-20 of 71

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.